Mbx Biosciences
Clinical trials sponsored by Mbx Biosciences, explained in plain language.
-
New weekly shot could ease hypoparathyroidism treatment burden
Disease control CompletedThis study tested a new medicine called MBX 2109, given once a week as a shot, in 64 adults with hypoparathyroidism. The goal was to see if it could safely help patients reduce their daily calcium and vitamin D pills while keeping blood calcium levels normal. The trial compared t…
Phase: PHASE2 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New drug MBX 2109 tested in people with kidney problems
Knowledge-focused CompletedThis study looked at how the experimental drug MBX 2109 behaves in the body and whether it is safe for people with different levels of kidney function. Twenty-five adults with normal or impaired kidneys received a single injection of the drug. The goal was to measure drug levels …
Phase: PHASE1 • Sponsor: MBX Biosciences • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC